Neuroleptics Up‐Regulate Adenosine A2a Receptors in Rat Striatum: Implications for the Mechanism and the Treatment of Tardive Dyskinesia

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Neurochemistry

• Publication date

  1995-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1046/j.1471-4159.1995.65052057.xPMID 7595490
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride

  2004cited by this paper
• Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: Studies with chronic clozapine and haloperidol

  2004cited by this paper
• Drugs and the treatment of psychiatric disorders

  1996cited by this paper
• Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.

  1995cited by this paper
• Dopamine receptor pharmacology.

  1994cited by this paper
• Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats.

  1994cited by this paper
• Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats.

  1994cited by this paper
• Nomenclature and classification of purinoceptors.

  1994cited by this paper
• Age‐Dependent Alterations in Dopamine Content, Tyrosine Hydroxylase Activity, and Dopamine Uptake in the Striatum of the Weaver Mutant Mouse

  1994cited by this paper
• Receptor‐receptor link in membranes revealed by ligand competition: Example for dopamine D1 and D2 receptors

  1994cited by this paper
• The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain

  1993cited by this paper
• EFFECTS OF NEUROLEPTICS ON NEURONAL AND SYNAPTIC STRUCTURE

  1993cited by this paper
• Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.

  1993cited by this paper
• The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum.

  1993cited by this paper
• Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion.

  1993cited by this paper
• Recent advances in the molecular biology of dopamine receptors.

  1993cited by this paper
• Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.

  1992cited by this paper
• Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

  1992cited by this paper
• General Pharmacology of Clozapine

  1992cited by this paper
• D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment.

  1992cited by this paper
• Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum.

  1992cited by this paper
• Adenosine-dopamine interactions in the brain.

  1992cited by this paper
• Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.

  1991cited by this paper
• Effect of Unilateral Perinatal Hypoxic‐Ischemic Brain Injury in the Rat on Dopamine D1 and D2 Receptors and Uptake Sites: A Quantitative Autoradiographic Study

  1991cited by this paper
• Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease.

  1991cited by this paper
• Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.

  1991cited by this paper
• Effect of unilateral perinatal hypoxic-ischemic brain injury on striatal dopamine uptake sites and D1 and D2 receptors in adult rats.

  1991cited by this paper
• Clozapine--a novel antipsychotic agent.

  1991cited by this paper
• Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study

  1991cited by this paper
• Clozapine. A novel antipsychotic agent.

  1991cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release.

  1990cited by this paper
• Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand

  1990cited by this paper
• Induction of c‐fos mRNA Expression in Rat Striatum by Neuroleptic Drugs

  1990cited by this paper
• Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

  1990cited by this paper
• Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.

  1989cited by this paper
• [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

  1989cited by this paper
• Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors.

  1989cited by this paper
• Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

  1989cited by this paper
• Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.

  1987cited by this paper
• Differential effects of pimozide and clozapine on schedule-controlled and scheduled-induced behaviors after acute and chronic administration.

  1987cited by this paper
• Dopamine receptors and the dopamine hypothesis of schizophrenia

  1987cited by this paper
• Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

  1985cited by this paper
• Adenosine as a neuromodulator.

  1985cited by this paper
• Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

  1984cited by this paper
• Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.

  1983cited by this paper
• Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.

  1982cited by this paper
• Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.

  1982cited by this paper
• Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive

  1982cited by this paper
• A study on the localization of [3H]sulpiride binding sites in rat striatal membranes.

  1981cited by this paper
• Changes in catalepsy and receptor sensitivity following chronic neuroleptic treatment.

  1981cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Antipsychotic drug doses and neuroleptic/dopamine receptors

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

  1976cited by this paper
• Effect of some phosphodiesterase inhibitors on central dopamine mechanisms.

  1976cited by this paper
• Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.

  1974cited by this paper
• Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism

  2022cites this paper
• Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study

  2021cites this paper
• Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging

  2018cites this paper
• Angiotensin II type 1/adenosine A2A receptor oligomers: a novel target for tardive dyskinesia

  2017cites this paper
• PET imaging of adenosine A2A receptors

  2017cites this paper
• In vivo evaluation of [11C]preladenant positron emission tomography for quantification of adenosine A2A receptors in the rat brain

  2017cites this paper
• Caractérisation neurochimique de la dyskinésie tardive dans un modèle primate non humain

  2017influential citation
• Tardive Dyskinesia: A Historical Perspective

  2017cites this paper
• Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data

  2016cites this paper
• Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies

  2016cites this paper
• Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1

  2015cites this paper
• Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model

  2014cites this paper
• Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.

  2014cites this paper
• Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.

  2012cites this paper
• Changes in A2A adenosine receptor parameters in patients affected by bipolar disorders: Correlation with antipsychotic dosage and severity of illness

  2012cites this paper
• Typical and atypical neuroleptics.

  2011cites this paper
• Adenosine A2A-Receptor Antagonism and Pathophysiology of Parkinson’s Disease and Drug-Induced Movement Disorders

  2011cites this paper
• Dopamine Receptors and the Treatment of Schizophrenia

  2010cites this paper
• Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes.

  2010cites this paper
• INFLUÊNCIA DE FÁRMACOS ANTIPSICÓTICOS SOBRE A HIDRÓLISE DE NUCLEOTÍDEOS EXTRACELULARES E ACETILCOLINA EM CÉREBRO DE ZEBRAFISH ( Danio rerio )

  2009cites this paper
• Università degli Studi di Ferrara DOTTORATO DI RICERCA IN " Farmacologia e Oncologia Molecolare "

  2009cites this paper
• Potential role of adenosine A2A receptors in the treatment of schizophrenia.

  2008cites this paper
• Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia.

  2007cites this paper
• Differential nigral expression of Bcl-2 protein family in chronically haloperidol and clozapine-treated rats: role in neurotoxicity and stereotyped behavior.

  2007cites this paper
• Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications.

  2006cites this paper
• Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.

  2006cites this paper
• Role of nigral NFκB p50 and p65 subunit expression in haloperidol-induced neurotoxicity and stereotyped behavior in rats

  2006cites this paper
• Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics.

  2006cites this paper
• Adenosine A2a receptor/dopamine D2 receptor hetero-oligomerization: a hypothesis that may explain behavioral sensitization to psychostimulants and schizophrenia.

  2005cites this paper
• Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson’s disease and schizophrenia

  2005cites this paper
• Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease.

  2005cites this paper
• ASSOCIAÇÃO ENTRE O POLIMORFISMO 2592C>TINS DO GENE DO RECEPTOR A2A DE ADENOSINA E A ESQUIZOFRENIA

  2004cites this paper
• Aberrant A2A receptor function in peripheral blood cells in Huntington's disease

  2003cites this paper
• Up-regulation of striatal adenosine A2A receptors in schizophrenia

  2003cites this paper
• Dopamine — Adenosine Interactions

  2002cites this paper
• Adenosine A2A, 5-HT1A and 5-HT7 receptor in neonatally pregnenolone-treated rats

  2001cites this paper
• Subchronic Treatment with Methamphetamine and Phencyclidine Differentially Alters the Adenosine A1 and A2A Receptors in the Prefrontal Cortex, Hippocampus, and Striatum of the Rat

  2001cites this paper
• Chronic Treatment with Clozapine, but Not Haloperidol, Increases Striatal Ecto-5′-Nucleotidase Activity in Rats

  2001cites this paper
• Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum.

  2001cites this paper
• 11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand.

  2000cites this paper
• Selective Adenosine A2AReceptor Antagonism as an Alternative Therapy for Parkinson's Disease

  2000cites this paper
• Adenosine A2A receptor gene expression in the normal striatum and after 6-OH-dopamine lesion

  2000cites this paper
• Schizophrenia: a purinergic hypothesis.

  2000cites this paper
• Clozapine-induced neuroleptic malignant syndrome: an interaction between dopaminergic and purinergic systems?

  1999cites this paper
• Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators.

  1999cites this paper
• Cyclosporine A and purinergic receptors in rat kidney.

  1999cites this paper
• Indirect Modulation of Dopamine D2 Receptors as Potential Pharmacotherapy for Schizophrenia: I. Adenosine Agonists

  1999cites this paper
• Involvement of Adenosine A2A Receptors in the Induction of C-Fos Expression by Clozapine and Haloperidol

  1999cites this paper
• Distribution, biochemistry and function of striatal adenosine A2A receptors.

  1999cites this paper
• Central adenosine A(2A) receptors: an overview.

  1999cites this paper
• Cellular distribution of adenosine A2A receptor mrna in the primate striatum

  1998cites this paper
• Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia.

  1998cites this paper
• An increase in [3H] CGS21680 binding in the striatum of postmortem brains of chronic schizophrenics.

  1998cites this paper
• Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats

  1998cites this paper
• Caffeine--an atypical drug of dependence.

  1998cites this paper
• Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.

  1997cites this paper
• Prolonged treatment with haloperidol and clozapine in the rat: differential effects on spontaneous and theophylline-induced motor activity.

  1997cites this paper
• Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones

  1997cites this paper
• Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia.

  1997cites this paper
• Adenosine-dopamine interactions in the ventral striatum Implications for the treatment of schizophrenia

  1997influential citation
• Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic

  1997cites this paper